There were 836 press releases posted in the last 24 hours and 442,539 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Proteostasis Therapeutics, Inc. Demonstrates Therapeutic Potential of a Proprietary Triple Combination Therapy for the Treatment of Cystic Fibrosis That Restores Activity of Mutant F508del CFTR Protein to 80% of Normal

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image